(Q37336643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Molecular targets and targeted therapies in bladder cancer management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Ramy F Youssef

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Georg Bartsch

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Peter A Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Donald G Skinner

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Richard J Cote

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

28 November 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

published in

World Journal of Urology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

9-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19039591%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00345-008-0357-x

17 January 2020

exact match

0 references

cites work

Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Prognostic value of epidermal growth factor-receptor, T138 and T43 expression in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Tumor grade-dependent alterations in the protein kinase C isoform pattern in urinary bladder carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Bladder cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Searching for novel therapeutics and targets: insights from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-008-0357-X

Adjuvant chemotherapy for invasive bladder cancer (individual patient data)

21 January 2018

1 reference

12 December 2020

Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history

1 reference

12 December 2020

Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells

1 reference

12 December 2020

Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer

1 reference

12 December 2020

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression

1 reference

12 December 2020

Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer

1 reference

12 December 2020

Human urinary bladder carcinomas express adenovirus attachment and internalization receptors

1 reference

12 December 2020

Combined treatment of bladder cancer cell lines with lapatinib and varying chemotherapy regimens--evidence of schedule-dependent synergy

1 reference

12 December 2020

Bevacizumab and erlotinib show promise for kidney cancer

1 reference

12 December 2020

Targeting EGFR in bladder cancer

1 reference

12 December 2020

Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis

1 reference

12 December 2020

Monoclonal antibodies in human cancer

1 reference

12 December 2020

Neo-adjuvant chemotherapy for invasive bladder cancer

1 reference

12 December 2020

hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours

1 reference

12 December 2020

Epidermal growth factor receptor inhibition in cancer therapy: biology, rationale and preliminary clinical results

1 reference

12 December 2020

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor

1 reference

12 December 2020

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

12 December 2020

Connecting proliferation and apoptosis in development and disease

1 reference

12 December 2020

Relationship of tumor angiogenesis and nuclear p53 accumulation in invasive bladder cancer.

1 reference

12 December 2020

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

12 December 2020

Molecular staging of bladder cancer.

1 reference

12 December 2020

Molecular pathogenesis and diagnostics of bladder cancer

1 reference

12 December 2020

Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice

1 reference

12 December 2020

Gene therapy for bladder cancer

1 reference

12 December 2020

Review: side effects of approved molecular targeted therapies in solid cancers.

1 reference

12 December 2020

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma

1 reference

12 December 2020

Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.

1 reference

12 December 2020

EGFR targeting of solid tumors

1 reference

12 December 2020

Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillation

1 reference

12 December 2020

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification

1 reference

12 December 2020

HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder: prognostic implications

1 reference

12 December 2020

Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer

1 reference

12 December 2020

Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors

1 reference

12 December 2020

Targeting vasculature in urologic tumors: mechanistic and therapeutic significance

1 reference

12 December 2020

Expression of c-myc protein is related to cell proliferation and expression of growth factor receptors in transitional cell bladder cancer

1 reference

12 December 2020

Mitogenic signal transduction pathways in meningiomas: novel targets for meningioma chemotherapy?

1 reference

12 December 2020

Understanding the importance of smart drugs in renal cell carcinoma

1 reference

12 December 2020

Molecular markers for bladder cancer: the road to a multimarker approach

1 reference

12 December 2020

The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing

1 reference

12 December 2020

Self-regulation of growth in three dimensions

1 reference

12 December 2020

Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer

1 reference

12 December 2020

Combination targeted therapy with sorafenib and bevacizumab results in enhanced toxicity and antitumor activity

1 reference

12 December 2020

Gefitinib ('Iressa', ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2.

1 reference

12 December 2020

p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer

1 reference

12 December 2020

Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.

1 reference

12 December 2020

The p53-mdm-2 autoregulatory feedback loop

1 reference

12 December 2020

Microvessel density as a prognostic marker in bladder carcinoma: correlation with tumor grade, stage and prognosis

1 reference

12 December 2020

Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome

1 reference

12 December 2020

Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer

1 reference

12 December 2020

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

1 reference

12 December 2020

Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (Stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group

1 reference

12 December 2020

Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21

1 reference

12 December 2020

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

12 December 2020

Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer

1 reference

12 December 2020

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

12 December 2020

The use of genetic programming in the analysis of quantitative gene expression profiles for identification of nodal status in bladder cancer

1 reference

12 December 2020

Signaling networks that link cell proliferation and cell fate

1 reference

12 December 2020

Biomarker profiling for cancer diagnosis, prognosis and therapeutic management

1 reference

12 December 2020

p53 and retinoblastoma pathways in bladder cancer.

1 reference

12 December 2020

Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy

1 reference

12 December 2020

Accumulation of nuclear p53 and tumor progression in bladder cancer.

1 reference

12 December 2020

Cell cycle targets of Ras/Raf signalling

1 reference

12 December 2020

Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling

1 reference

12 December 2020

Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder transitional cell carcinoma

1 reference

12 December 2020

p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer

1 reference

12 December 2020

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression

1 reference

12 December 2020

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

12 December 2020

Is vascular endothelial growth factor modulation a predictor of the therapeutic efficacy of gefitinib for bladder cancer?

1 reference

12 December 2020

Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting

1 reference

12 December 2020

Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature

1 reference

12 December 2020

Positive response to bevacizumab in a patient with metastatic, chemotherapy-refractory urothelial carcinoma

1 reference

12 December 2020

Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors

1 reference

12 December 2020

High-throughput tissue microarray analysis ofCMYC amplificationin urinary bladder cancer

1 reference

12 December 2020

Angiogenesis: initiation and modulation

1 reference

12 December 2020

Vascular endothelial growth factor and its receptors

1 reference

12 December 2020

Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors

1 reference

12 December 2020

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

1 reference

12 December 2020

The global burden of urinary bladder cancer.

1 reference

12 December 2020

p53 and treatment of bladder cancer

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design

1 reference

12 December 2020

Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression

1 reference

12 December 2020

Role of protein kinase C-alpha in superficial bladder carcinoma recurrence

1 reference

12 December 2020

The relation between survival and expression of HER1 and HER2 depends on the expression of HER3 and HER4: a study in bladder cancer patients

1 reference

12 December 2020

Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial

1 reference

12 December 2020

Targeted therapy for solid tumors: current status

1 reference

12 December 2020

Molecular biology of bladder cancer: prognostic and clinical implications.

1 reference

12 December 2020

Overexpression of c-erbB-2 oncoprotein in muscle-invasive bladder carcinoma: relationship with gene amplification, clinicopathological parameters and prognostic outcome

1 reference

12 December 2020

Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors

1 reference

12 December 2020